Daewoong’s Ursa mired in efficacy dispute

Daewoong Pharmaceutical, one of the country's biggest drug makers, has built its reputation on its immensely popular liver medicine, Ursa (ursodeoxycholic acid; UDCA), but its efficacy is mired in controversy due to a report by a local media.

Last Friday, the media argued that Ursa is almost similar to a simple digestive drug as the drug has no effect on the metabolism of alcohol and is only...